Ocugen's consensus analyst price target has remained steady at $8.20, indicating no change in the long-term outlook for the stock. Despite ongoing industry shifts, analysts appear to be holding firm ...

The tally of “zombie companies” in the US that aren’t earning enough to cover their interest expenses stands at the highest ...

With federal subsidies decreasing, more than a million people in Texas are expected to opt out of coverage. Here's what you ...